Year-on-Year Variations:
2024-2025: 2.44%
2025-2026: 2.34%
2026-2027: 2.31%
2027-2028: 2.22%
The sales of systemic hormonal preparations (excluding sex hormones and insulins) in Spain are forecasted to grow steadily from 450.2 million euros in 2024 to 493.6 million euros by 2028. The average CAGR over these five years is approximately 2.32% annually.
Future Trends to Watch: Increasing prevalence of chronic diseases and advancements in hormonal therapies are likely to drive market growth. Additionally, an aging population may further elevate demand for these treatments, potentially influencing future sales forecasts positively.
